Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Waiting for The Big One

David S. Pisetsky, MD, PhD  |  Issue: December 2008  |  December 1, 2008

In all of my years at ACR meetings, I have never witnessed so much talk about an election nor the display of so many campaign buttons and t-shirts. I suspect that some people from red states could, in the city of San Francisco—a preserve of blue political sentiments par excellence—raise their political voices and, in the tradition of the city in another realm, come out of the closet, so to speak.

Perhaps my political leanings are apparent, but just about everyone to whom I spoke assumed that I supported Obama and that “we” represented the rheumatology wing of the Democratic Party. I felt that same way I do the week before the Duke–Carolina basketball game when someone at the medical center says that “we” are going to win. Of course, “we” are the Blue Devils and there is no way in hell that “we” could be the despised, reviled, and contemptible Tar Heels.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Ambivalence at Home and Abroad

Not surprisingly, the ACR contingent from Europe was just about all in favor of Obama. In most of the countries there, even the most conservative parties stand to the left of our liberals. The Europeans are social democrats after all and, while private healthcare insurance may be growing, the European countries all have tax-funded universal healthcare coverage. I did not meet any Russians in San Francisco. It’s too bad that they don’t come to spend their petro-rubles on real CME, because an exchange with that colossus would be very worthwhile.

The interest of the Europeans in U.S. politics is not a matter of idle curiosity. The world is flat as a pancake; witness the financial ripples around the world because of the failure of Iceland’s banks. In a global economy, where all transactions are linked electronically at lightning speed, when the U.S. catches a cold, everyone sneezes. Right now there is a whole lot of sneezing going on. If I had money to invest, I would take a strong position in Kleenex stock.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

As evident in myriad conversations, remarks, and even jokes, just about everyone at the ACR was worried that, economically, we may be in the midst of a “big one.” During sessions in the dark of the giant halls, people peered down at the flickering screens of their BlackBerries and iPhones to catch the latest on the Dow Jones Index as the stock market bounced wildly. More than one lecturer talked about the state of his 401(k). As a scientist at an ACR meeting, when I hear the words “401K,” I usually think of a really big protein and not a retirement plan.

Page: 1 2 3 | Single Page
Share: 

Filed under:Meeting ReportsOpinionRheuminationsSpeak Out Rheum Tagged with:ACR MeetingACR NewsACR/ARHP Annual MeetingCME

Related Articles

    ACR Convergence: Stronger Than Ever After More Than 8 Decades

    July 13, 2022

    Like solving sudoku, planning the ACR annual meeting requires an ability to recognize patterns and employ focused logical thinking, all the while remaining undaunted by the various paths possible to complete a grid from what looks like, at initial glance, an incomprehensible labyrinth of options. The patterns in this situation are not numbers, but sessions,…

    Plan Now to Attend the 2016 ACR/ARHP Annual Meeting

    Plan Now to Attend the 2016 ACR/ARHP Annual Meeting

    August 10, 2016

    Where can you network with more than 16,000 professionals in the field of rheumatology? Where you can hear about promising research and best practices from industry leaders? How can you find out about new treatments and technologies on the horizon? You guessed it—at the 2016 ACR/ARHP Annual Meeting, to be held Nov. 11–16. As if…

    Research and the Economic “Big One”

    January 1, 2009

    The fortunes of industry and academia may rise and fall together

    Set Your Sights on San Diego: Register Now for the 2017 ACR/ARHP Annual Meeting

    July 7, 2017

    The 2017 ACR/ARHP Annual Meeting will be in San Diego, Nov. 3–8. Here is a taste of what this unique and fun city offers attendees…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences